<?xml version="1.0" encoding="UTF-8"?>
<p>As pointed out by Bogaert et al., the lack of publicly available data on stockouts and problems surrounding definitions of stockouts and shortages have led to limited global quantification of stockouts and the identification of their causes. In that qualitative study, European stakeholders identified manufacturing, economic, supply and distribution problems, as the main causes of stockouts [
 <xref rid="pone.0191294.ref040" ref-type="bibr">40</xref>]. The WHA69.25 resolution “Addressing the Global Shortage of Medicines and Vaccines”, which followed increased global reporting of drug shortages, echoed those challenges [
 <xref rid="pone.0191294.ref015" ref-type="bibr">15</xref>]. A report commissioned by the European Association of Euro-Pharmaceutical Companies distinguished between predictable and unpredictable causes of stockouts [
 <xref rid="pone.0191294.ref041" ref-type="bibr">41</xref>]. In the DRC, predictable, mainly logistical challenges like just-in-time inventories, poor forecasting and transport problems, seem to be the most important drivers explaining stockouts [
 <xref rid="pone.0191294.ref021" ref-type="bibr">21</xref>]. On top of that, more than in most developing countries, medicines stockouts are exacerbated by unpredictable causes such as political unrest, financial crisis and recurrent epidemics [
 <xref rid="pone.0191294.ref042" ref-type="bibr">42</xref>]. Creation of reliable in-country supply chains has been recognised by the UN as a priority to reach 90-90-90 targets in West-and Central Africa [
 <xref rid="pone.0191294.ref014" ref-type="bibr">14</xref>].
</p>
